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Dry Eye Disease
D ry eye symptoms, reported by about 25% of patients, areone of the most common reasons for patient visits to eye-care professionals.1 As various ocular surface conditions
or diseases can lead to the same ocular symptoms, diagnosing,
treating, and managing patients with dry eye symptoms can be
challenging and frustrating to both clinicians and patients. Since
the notable Tear Film and Ocular Surface Society’s international
workshops on Dry Eye Workshop and meibomian gland dys-
function (MGD),2,3 awareness of how significantly dry eye symp-
toms negatively impact quality of life has risen. In the past decade,
clinicians and scientists have made significant strides in improv-
ing care for patients with dry eye symptoms. This special issue of
Optometry and Vision Science highlights a collection of reviews, origi-
nal articles, clinical reports, and clinical perspectives that provide
readers with updates regarding the diagnosis, treatment, and manage-
ment of dry eye symptoms that result from various causes. Our con-
tributor articles are reported here under the topics of Risk Factors,
Diagnosis, Treatment and Management, and Clinical Perspectives.
Risk Factors
Prevalence of dry eye varies considerably depending on diagnostic
criteria, study designs, and regions of the world where studies are
conducted. It has been reported that among women, Asians are
significantly more likely to experience severe dryness symptoms.4
Several known risk factors of dry eye are applicable to Chinese
patients, and some distinctive dietary factors may be protective in
this population.5 Of known risk factors, contact lens wear is highly
associated with dry eye symptoms; however, mechanisms responsible
for this association are not clearly understood. Contact lens wear may
be associated with meibomian gland atrophy; however, conflicting
results have been reported and a longitudinal prospective study is
warranted.6 Contact lensYinduced dry eye and binocular vision
disorders are reported to share several common symptoms.7 Further
understanding about the relationship between these disorders can
help clinicians to better manage contact lensYinduced dry eye.
Another common risk factor for dry eye symptoms is topical
antiglaucoma ophthalmic medications and their associated pre-
servatives. We learn that increasing the frequency of antiglaucoma
medication doses or types of drops increases the odds of having
ocular surface disease and dry eye symptoms.8,9 Some nonpreserved
glaucoma medications may also have adverse effects on ocular sur-
face health, resulting in a higher prevalence of ocular surface diseases
among treated glaucoma patients.8 Laser-assisted in situ keratomil-
eusis (LASIK) is another significant risk factor; it injures the subbasal
nerve plexus during the lamellar cut of the procedure. Nearly 50%
of post-LASIK patients experience dry eye symptoms.10 Blink
anomalies can significantly exacerbate post-LASIK dry eye symp-
toms.11 Some cases of post-LASIK dry eye are neuropathic in eti-
ology and warrant treatment of the underlying neuralgia rather than
treatment of aqueous-deficient or evaporative dry eye, according to
our authors.10
One of the most common types of evaporative dry eye is thought
to be MGD. Meibomian glands are the main source of tear lipids,
which are essential for retardation of tear aqueous evaporation. We
learn that patients with a history of acne treatment using isotretinoin
can also have dry eye symptoms because of damaged meibomian
glands.12 The effect of isotretinoin on the meibomian glands likely
mimics its effects on the sebaceous glands of the skin in the treatment
of acne.12 Consequently, it is important for clinicians to be aware
of isotretinoin-associated MGD, especially on young adults. It is
also important to note that another common cause of evapora-
tive dry eye, frequently underdiagnosed, is lagophthalmos or in-
complete blink.13
Diagnosis
A stable tear film is essential for maintaining ocular surface
homeostasis and for providing good vision and ocular comfort.
Understanding mechanisms responsible for tear film stability may
be facilitated with the aid of infrared thermography described here.14
Ocular surface cooling always precedes tear film breakup.14 The lag
time between tear cooling and breakup is explained by the time
necessary to first disrupt the tear lipid layer that eventually forms
a localized rupture, which accelerates evaporation.14 Tear film
stability can be assessed with an invasive method (e.g., instilling
fluorescein dye on the eye) or with a noninvasive method (e.g., placido
rings projecting on the precorneal tear film or other custom-built
optical devices). However, the invasiveness of fluorescein applica-
tion can potentially perturb the tear lipid layer, causing an inaccurate
assessment of tear film stability; therefore, the volume of fluorescein
dye should be minimized. The traditionally accepted diagnostic
threshold of dry eye using tear breakup time is 10 seconds. It is
reported that using a traditional threshold of 10 seconds may yield
false-positive cases if applied on Asian populations.15 In another
study, a direct comparison with automated and traditional measures
of tear film breakup shows poor agreement, perhaps because each
method exhibits poor repeatability.15,16 Further research is needed
to refine and improve methods for assessing tear film stability as it is
considered an important end point in clinical trials.
Increased tear osmolarity can be amplified by either increased
tear evaporation or decreased tear supply. An accurate measurement
of tear osmolarity on a localized ocular surface is not a trial task and is
currently not possible. Taking osmolarity measurements from the
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tear meniscus is the basis for current osmometers. The utility of
these tools in a clinical setting continues to be debatable relative
to their reflection of what truly happens to the precorneal tear
film.16,17 In addition to natural lability of tear film and instru-
ment variability, we have a report of test outcomes of tear film
being climate dependent.18
In recent years, in vivo laser scanning confocal microscopy,
providing in vivo cytology of the ocular surface, has been reported
as a useful tool to diagnose neuropathic dry eyes and monitor
treatment effect by measuring density of corneal nerves and in-
flammatory cells, as inflammation plays an important role in the
pathogenesis of many dry eye cases.19
Treatment and Management
A number of our articles here address both treatment and
management of dry eye. Understanding tear film constituents and
regulatory mechanisms for natural production of tear compo-
nents can be used to develop new concepts for potential treatment
strategies. Mucins play a major role in maintaining ocular surface
homeostasis by lubricating and protecting the ocular surface as
well as providing immunomodulatory function, acting as antimi-
crobial factors and preventing pathogens from binding to the ocular
surface and clearing away pathogens.20 An ophthalmic solution
containing diquafosol tetrasodium offers an alternate treatment
option to restore ocular surface integrity by stimulating goblet-cell
secretion of ocular mucins.21,22 For advanced cases of aqueous tear
deficiency or ocular surface diseases, other treatment and manage-
ment options are available, such as thermal and electrocautery of
the lacrimal puncta, lid surgeries such as tarsorrhaphy, amniotic
membrane, or scleral lens fitting.23
In today’s society, even healthy eyes can experience temporary
discomfort because of prolonged reading or viewing of computers
or other electronic devices. Our authors offer software programs
available for computers or smartphones to remind users to take
visual breaks or blink more frequently to minimize stress to the
tear film.24 Other authors, in a review, draw attention to the fact
that there are conflicting reports about the benefits of Omega-3
supplements and raise questions that warrant a longitudinal ran-
domized controlled clinical trial to provide appropriate guidance
on formulation, dosage, and duration of this essential fatty acid.25
Eyelid margin debridement has gained much attention in recent
years and studies, including a report in this issue, noting improve-
ments in symptoms and signs after the procedure for patients with
Sjogren or non-Sjogren dry eye.26 Self-applied heat therapy has been
the mainstay of therapy for MGD; however, a clinical series reported
here reveals that not all warm compresses are equally effective.27,28
Although much more costly than traditional warm compresses, some
symptomatic patients with MGD find LipiFlow (Thermal Pulsation
System) treatment to be beneficial. One team of authors suggests
that an appropriate patient selection may increase patient satisfac-
tion with this procedure.29
Clinical Perspectives
Experts from different parts of the world have varying opinions
about the most viable diagnostic methodologies and treatments.13
In fact, dry eye disease may be the wrong term to describe an eye
that is not desiccated. Arguments are made that an etiology-based
diagnosis allows clinicians to more effectively treat and manage
dry eye symptoms, compared with symptom-based or definition-
based approaches.13,30 Until more novel treatment strategies are
developed to restore and/or enhance tear gland function and ocular
surface integrity, many treatment options addressing the signs and
symptoms will remain primarily palliative. But as noted in this issue,
hope for advanced treatments emerging through the pipeline is on
the horizon.
REFERENCES
1. O’Brien PD, Collum LM. Dry eye: diagnosis and current treatment
strategies. Curr Allergy Asthma Rep 2004;4:314Y9.
2. Research in dry eye: report of the Research Subcommittee of the
International Dry Eye WorkShop (2007). Ocul Surf 2007;5:179Y93.
3. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M,
Tsubota K, Lemp MA, Sullivan DA. The international workshop on
meibomian gland dysfunction: executive summary. Invest Ophthalmol
Vis Sci 2011;52:1922Y9.
4. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of
dry eye syndrome among US women. Am J Ophthalmol 2003;136:
318Y26.
5. Yang W, Yang Y, Cao J, Man Z, Yuan J, Xiao X, Xing Y. Risk factors
for dry eye syndrome: A retrospective case-control study. Optom Vis
Sci 2015;92:e199Y205.
6. Pucker AD, Jones-Jordan LA, Li W, Kwan JT, Lin MC, Sickenberger
W, Marx S, Srinvasan S, Jones L. Associations with meibomian gland
atrophy in daily contact lens wearers. Optom Vis Sci 2015;92:
e206Y13.
7. Rueff EM, King-Smith PE, Bailey MD. Can binocular vision dis-
orders contribute to contact lens discomfort? Optom Vis Sci 2015;92:
e214Y21.
8. Ramli N, Supramaniam G, Samsudin A, Juana A, Zahari M, Choo
MM. Ocular surface disease in glaucoma: effect of polypharmacy and
preservatives. Optom Vis Sci 2015;92:e222Y6.
9. Chen H, Lin C, Tsai Y, Kao C. Association between glaucoma med-
ication usage and dry eye in Taiwan. Optom Vis Sci 2015;92:e227Y32.
10. Theophanous C, Jacobs DS, Hamrah P. Corneal neuralgia after
LASIK. Optom Vis Sci 2015;92:e233Y40.
11. McMonnies CW. How Blink Anomalies Can Contribute to Post-
LASIK Neurotrophic Epitheliopathy. Optom Vis Sci 2015;92:e241Y7.
12. Moy A, McNamara NA, Lin MC. Effects of isotretinoin on
Meibomian glands. Optom Vis Sci 2015;92:925Y30.
13. Lin MC, Polse KA. Improving care for patients with dry eye symp-
toms: see what the experts say. Optom Vis Sci 2015;92:e342Y9.
14. Li W, Graham AD, Selvin, Lin MC. Ocular surface cooling cor-
responds to tear film thinning and breakup. Optom Vis Sci 2015;
92:e248Y56.
15. Yeh TN, Graham AD, Lin MC. Relationships among Tear Film
Stability, Osmolarity, and Dryness Symptoms. Optom Vis Sci 2015;
92:e264Y72.
16. Cox SM, Nichols KK, Nichols JJ. Agreement between automated
and traditional measures of tear film breakup. Optom Vis Sci 2015;92:
e257Y63.
17. Pena-Verdeal H, Garcia-Resua C, Min˜ones M, Gira´ldez MJ, Yebra-
Pimentel E. Accuracy of a freezing point depression technique os-
mometer. Optom Vis Sci 2015;92:e273Y83.
Guest EditorialVLin et al. 923
Optometry and Vision Science, Vol. 92, No. 9, September 2015
Copyright © American Academy of Optometry. Unauthorized reproduction of this article is prohibited.
18. Teso´n M, Lo´pez-Miguel A, Neves H, Calonge M, Gonza´lez-Garcı´a
MJ, Gonza´lez-Me´ijome JM. Influence of climate on clinical diag-
nostic dry eye tests: a pilot study. Optom Vis Sci 2015;92:e284Y9.
19. Villani E, Garoli E, Termine V, Pichi F, Ratiglia R, Nucci P. Corneal
confocal microscopy in dry eye treated with corticosteroids. Optom
Vis Sci 2015;92:e290Y5.
20. Stephens DN, McNamara NA. Altered mucin and glycoprotein
expression in dry eye disease. Optom Vis Sci 2015;92:931Y8.
21. Yang JM, Choi W, Kim N, Yoon KC. Comparison of topical cy-
closporine and diquafosol treatment in Dry Eye. Optom Vis Sci
2015;92:e296Y302.
22. Kobashi H, Kamiya K, Igarash A, Miyake T, Shimizu K. Intraocular
scattering after instillation of diquafosol ophthalmic solution. Optom
Vis Sci 2014;92:e303Y9.
23. Bartlett AH, Bartlett JD. Ophthalmic procedures for treatment of
advanced ocular surface diseases. Optom Vis Sci 2015;92:939Y47.
24. Nosch DS, Foppa D, To´th M, Joos RE. Blink animation software to
improve blinking and dry eye symptoms. Optom Vis Sci 2015;92:
e310Y5.
25. Hom MM, Asbell PA, Barry B. Omegas and dry eye: more
knowledge, more questions. Optom Vis Sci 2015;92:948Y56.
26. Ngo W, Caffery B, Srinivasan S, Jones L. The Effect of lid debridement-
scaling in Sjo¨gren’s syndrome dry eye. Optom Vis Sci 2015;92:e316Y20.
27. Wang M, Jaitley Z, Lord SM, Craig JP. Comparison of self-applied
heat therapy for Meibomian gland dysfunction. Optom Vis Sci 2015;92:
e321Y6.
28. Murkami DK, Blackie CA, Korb DR. All warm compresses are not
equally efficacious. Optom Vis Sci 2015;92:e327Y33.
29. Satjawatcharaphong P, Ge S, Lin MC. Clinical outcomes associated
with thermal pulsation system. Optom Vis Sci 2015;92:e334Y41.
30. Blackie CA, Korb DR. ‘‘Dry Eye’’ is the wrong diagnosis for millions.
Optom Vis Sci 2015;92:e350Y4.
Meng C. Lin
Berkeley, CA
Penny A. Asbell
New York, NY
Todd Margolis
St. Louis, MO
Nancy A. McNamarra
San Francisco, CA
Kelly K. Nichols
Jason J. Nichols
Birmingham, AL
Kenneth A. Polse
Berkeley, CA
924 Guest EditorialVLin et al.
Optometry and Vision Science, Vol. 92, No. 9, September 2015
Copyright © American Academy of Optometry. Unauthorized reproduction of this article is prohibited.
